BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12632454)

  • 1. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
    Seitz M; Villiger PM
    Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P; Nitschmann S
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
    Yazici Y; Yazici H
    Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
    [No Abstract]   [Full Text] [Related]  

  • 4. COMET's path, and the new biologicals in rheumatoid arthritis.
    Kremer JM
    Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
    van der Heijde D; Klareskog L
    Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
    Cutolo M
    Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
    van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
    Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
    Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
    Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.
    Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T;
    Ann Rheum Dis; 2013 Feb; 72(2):310-2. PubMed ID: 22975754
    [No Abstract]   [Full Text] [Related]  

  • 10. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
    Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
    Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate.
    Kavanaugh A; Klareskog L; van der Heijde D; Li J; Freundlich B; Hooper M
    Ann Rheum Dis; 2008 Oct; 67(10):1444-7. PubMed ID: 18535115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
    Bathon JM; Martin RW; Fleischmann RM; Tesser JR; Schiff MH; Keystone EC; Genovese MC; Wasko MC; Moreland LW; Weaver AL; Markenson J; Finck BK
    N Engl J Med; 2000 Nov; 343(22):1586-93. PubMed ID: 11096165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMET results are not stellar.
    James M; Cleland L
    Lancet; 2008 Nov; 372(9652):1807-8; author reply 1808. PubMed ID: 19027480
    [No Abstract]   [Full Text] [Related]  

  • 14. Etanercept in rheumatoid arthritis.
    Cook DA; Dimick JB; Gallagher DC
    N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of rheumatoid arthritis: a review of recent clinical trials.
    Mikuls T; Moreland L
    Curr Rheumatol Rep; 1999 Dec; 1(2):135-8. PubMed ID: 11123027
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
    Ferraccioli G
    Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [So that the patients.would be able to move for a long time after first diagnosis of rheumatism. Approach as an emergency!].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):4-5. PubMed ID: 15887690
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
    Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.
    Yazici Y; Yazici H
    Clin Exp Rheumatol; 2008; 26(3):449-52. PubMed ID: 18578967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap of systemic sclerosis and rheumatoid arthritis.
    Alkassab F
    J Rheumatol; 2007 Jul; 34(7):1593-4. PubMed ID: 17611965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.